Guillain-Barre syndrome (GBS) is a rare autoimmune condition that can lead to rapid muscle weakness and even paralysis if not treated. Various treatment options are available for Guillain-Barre syndrome that can alleviate symptoms and help individuals regain function.
Get Your IVIG Dose
At-Home InfusionFrom plasmapheresis to IVIG and physical therapy, each treatment offers advantages that can support patients at different stages of the disease.
In this guide, we will explore the most effective treatments for Guillain-Barre syndrome. We will dive deeper into their mechanisms, examine the studies assessing their efficacy, and review the drugs healthcare providers often prescribe for those with Guillain-Barre syndrome.
Understanding Guillain-Barre Syndrome
Guillain-Barre syndrome occurs when the body mistakenly attacks the peripheral nervous system. The exact cause of GBS remains unclear. However, it usually follows a viral infection or other triggering events like gastrointestinal illnesses.
The appropriate treatment for Guillain-Barre syndrome is determined based on each individual’s symptoms, which may vary in severity and can develop over hours or days. Common symptoms of GBS include:
- Loss of reflexes
- Pain or discomfort
- Heart rate abnormalities
- Difficulty with eye movements
- Bowel and bladder dysfunction
- Weakness or tingling in the legs
- Rapid onset of muscle weakness
- Difficulty walking or climbing stairs
Without timely intervention, patients may face severe muscle weakness, paralysis, respiratory failure, and other life-threatening conditions. They may also experience prolonged recovery times and long-term disabilities.
Treatment Options
GBS is a treatable condition with prompt diagnosis and intervention. Most patients who receive Guillain-Barre syndrome treatments early can experience significant recovery, with 80% being able to walk independently within 6 months of diagnosis.
Several Guillain-Barre syndrome treatment options are currently available that can help manage symptoms and improve recovery outcomes. These treatments include:
- Plasmapheresis (plasma exchange)
- Intravenous immunoglobulin (IVIG) therapy
- Medication therapy
- Occupational and physical therapy
Supportive Care During Acute Guillain-Barre Syndrome
In addition to disease-specific treatments, supportive care plays a critical role in managing Guillain-Barre syndrome, particularly during the acute phase of the illness. Some patients may require hospitalization or intensive care monitoring if symptoms progress rapidly.
Supportive care measures may include:
- Respiratory monitoring to assess breathing function and determine whether mechanical ventilation is needed.
- Cardiac monitoring to detect heart rhythm abnormalities caused by autonomic nervous system involvement.
- Blood clot prevention through medication and mobility interventions.
- Nutritional support for individuals who experience difficulty swallowing.
- Prevention of pressure sores and other complications associated with prolonged immobility.
Early recognition and management of these complications can significantly improve patient outcomes and reduce the risk of life-threatening events.
It is important to distinguish between treatments that address the underlying immune attack and those that help manage symptoms. Plasma exchange and IVIG are considered the primary disease-modifying treatments for Guillain-Barre syndrome because they target the immune processes responsible for nerve damage. Other medications are typically used to relieve symptoms such as pain, discomfort, or complications related to immobility.
Plasmapheresis
Plasmapheresis is a plasma exchange procedure that uses a machine to remove circulating antibodies and other immune factors that contribute to nerve damage in Guillain-Barre syndrome. Once these antibodies are removed, the blood is returned to the body. By reducing harmful immune activity, plasmapheresis may help shorten symptom duration and support faster recovery.
Research shows that Guillain-Barre patients undergoing this treatment tend to regain the ability to walk sooner than those who only receive supportive care and drugs for Guillain-Barre syndrome.
For instance, one trial reported a median recovery time of 30 days for those who received plasma exchange compared to 44 days for those who did not.
In addition to faster recovery times, those receiving plasmapheresis for Guillain-Barre syndrome have a higher rate of improvement in motor function. Although some patients may experience treatment-related complications or symptom recurrence, plasma exchange remains one of the most effective evidence-based treatments for Guillain-Barre syndrome.
Get IVIG Copay Assistance
Speak to a SpecialistIntravenous Immunoglobulin (IVIG Therapy)
Intravenous immunoglobulin therapy (IVIG) is often given to patients to help treat antibody deficiencies or conditions that release harmful antibodies in the blood, such as autoimmune diseases or antibody deficiency disorders.
This treatment for Guillain-Barre syndrome uses antibodies collected from donated blood plasma. Although the exact mechanism is not fully understood, IVIG is believed to work by modulating the immune system (blocking antibodies) and reducing the inflammatory processes responsible for nerve damage. The therapy is administered intravenously over several days under medical supervision.
Studies show promising results for IVIG therapy. For instance, a review of 12 trials with over 600 participants highlighted that IVIG significantly hastened recovery compared to supportive care and was as effective as plasma exchange therapy.
Another study showed that a greater increase in serum IgG levels after treatment was associated with improved recovery outcomes for patients with Guillain-Barre syndrome. These patients were more likely to regain the ability to walk independently within 6 months.
Corticosteroids have been studied as a potential treatment for Guillain-Barre syndrome. However, current evidence indicates that corticosteroids alone do not improve recovery outcomes and are generally not recommended as a primary treatment for GBS.
Medications
Pain medications may be administered to ease pain caused by GBS. If the patient experiences significant weakness or prolonged immobility, healthcare providers may also prescribe medications to help prevent blood clots and other complications.
While these medications do not treat the underlying cause of Guillain-Barre syndrome, they may help manage pain, discomfort, and complications that can occur during recovery. Common symptom-management medications include:
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): These medications, such as ibuprofen or naproxen, help reduce inflammation and alleviate pain in muscles and joints.
- Acetaminophen: This over-the-counter pharmacological treatment can help manage mild to moderate pain in Guillain-Barre patients and is often used in conjunction with other pain medications.
- Narcotic Analgesics (Opioids): For more severe pain, doctors may prescribe opioids. These medications work by binding to opioid receptors in the brain to reduce the perception of pain. However, they can have side effects and a risk of dependency.
- Gabapentin: Used primarily for neuropathic pain, gabapentin can help relieve burning or stabbing sensations associated with nerve damage in GBS.
- Carbamazepine: Similar to gabapentin, carbamazepine is another adjuvant treatment for Guillain-Barre syndrome that’s beneficial for managing neuropathic pain.
- Capsaicin Cream: Capsaicin cream is derived from chili peppers and applied topically. It diminishes substance P, a neurotransmitter involved in pain signaling.
- Tricyclic Antidepressants (TCAs): Drugs like amitriptyline may also be utilized for Guillain-Barre syndrome as an adjuvant treatment due to their analgesic properties in treating chronic pain. They work by altering neurotransmitter activity in the brain, which can help reduce pain perception.
Ask About IVIG Home Infusion
Occupational and Physical Therapy
To help maintain mobility, preserve joint flexibility, and restore functional independence, healthcare providers often recommend occupational and physical therapy. Rehabilitation is an important component of recovery from Guillain-Barre syndrome. Exercise programs should be individualized based on a patient’s strength, fatigue levels, and stage of recovery, with guidance from qualified healthcare professionals.
Because fatigue is a common symptom of Guillain-Barre syndrome, patients should avoid overexertion during rehabilitation. Exercise intensity should be increased gradually, and treatment plans should be adjusted if symptoms worsen or excessive fatigue develops.
One trial compared high-intensity exercise to lower-intensity regimens in 79 chronic-phase patients. Results showed that those engaging in high-intensity exercises experienced a significant reduction in disability, with 80% achieving improvements in mobility compared to just 8% in the lower-intensity group.
Another study highlighted that 12 weeks of structured exercise led to notable enhancements in cardiopulmonary function and strength, underscoring the benefits of physical activity in addition to the primary Guillain-Barre syndrome treatments.
Recommended Rehabilitation Activities
In addition to the main treatments and drugs for Guillain-Barre syndrome, your healthcare team might recommend working with an occupational or physical therapist for faster recovery. Some common exercises these professionals might suggest to support your Guillain-Barre syndrome treatment include:
- Strengthening Exercises: These exercises are focused on building muscle strength and may include resistance band workouts or weightlifting to enhance overall physical capabilities.
- Aerobic Training: Activities like cycling or walking, performed 2-3 times a week, to improve cardiovascular health and stamina.
- Flexibility and Stretching Routines: These exercises involve stretching major muscle groups to maintain joint mobility and prevent stiffness.
- Balance and Coordination Drills: Incorporating exercises that focus on improving balance and coordination, such as standing on one leg or using stability balls.
- Functional Mobility Training: Activities that simulate daily tasks, enabling individuals receiving Guillain-Barre treatment to practice movements like standing up from a chair or walking.
- Gait Training: This exercise is focused on improving walking patterns and may include using parallel bars or treadmills under the supervision of a therapist.
Recovery Outlook
Recovery from Guillain-Barre syndrome varies from person to person. While many individuals regain most or all of their function within months, others may experience lingering weakness, fatigue, or nerve-related symptoms for a longer period. Early treatment, supportive care, and rehabilitation can help maximize recovery and improve long-term outcomes.
Conclusion
By following a personalized rehabilitation program under the supervision of healthcare professionals, individuals with GBS may improve strength, mobility, endurance, and overall quality of life throughout the recovery process. Recovery timelines vary, and consistent participation in therapy can help patients maximize their functional outcomes.
Receive Guillain-Barre Syndrome Treatment from AmeriPharma® Specialty Pharmacy
Guillain-Barre syndrome is a manageable disease when not overlooked and is promptly diagnosed and treated. With the mentioned treatments, symptoms of Guillain-Barre syndrome can be carefully monitored and treated according to severity based on each patient’s clinical status.
Whether you need IVIG therapy or drugs for Guillain-Barre syndrome, AmeriPharma® Specialty Pharmacy can help. Our ACHC-accredited specialty pharmacy offers home infusion services and hard-to-find medications to patients in over 40 U.S. states and territories.
Contact us today to speak to a patient navigator and explore our Guillain-Barre syndrome treatment options with full-service coordination, copay assistance, and 24/7/365 support.
